Microsoft word - final_programme_basis.doc

Thursday May 18, 2006

17:00 - 19:00

Registration

Friday May 19, 2006

from 07:30

Registration
Welcome Address

08:30 - 10:45

SESSION I
Chair:
Sophie Mavrogeni (Athens, Greece)
Guillem Pons-Llado (Barcelona, Spain)
1: Anatomy and right planning
2: How to find the right Pulse sequences
3: Fast Imaging
Sebastian Kozerke (Zürich, Switzerland) 4: Dealing with Artifacts
Albert van Rossum (Amsterdam, The Netherlands) 5: Evaluation of Function and Volumes
6: Flow-Measurements
Sebastian Globits (St. Pölten, Austria) 7: Tagging
8: Contrast agents
10:30 - 11:15
Coffee break

11:15 - 12:50
SESSION II
Assessment of CAD- Perfusion and Viability
Chair:
Sebastian Globits (St. Pölten, Austria)
Dudley Penell (London, UK)
9: Perfusion MR Imaging
10: Late-enhancement for myocardial viability
11: Dobutamine stress for myocardial viability
12: Case presentation 1
13: Case presentation 2
14: Case presentation 3

12:30 - 12:51
Oral Abstract Presentation
15: Combined Coronary Artery Imaging, Myocardial Perfusion and
Delayed Enhancement in Patients with Suspected Coronary Artery
Disease.

C. Klein; T. Kokocinski; R. Gebker; B.Schnackenburg; E. Fleck; E. Nagel.
German Heart Institute Berlin, Philips Medical Systems, Berlin, Germany
16: Risk stratification after reperfused acute myocardial infarction using
delayed contrast-enhanced cardiovascular magnetic resonance.

M. Regenfus, C. Stingl, C. Schlundt, J. von Erffa, M. Schmidt, W. Adler,
W. G. Daniel. Medical Clinic II and Institut of Biometry, FAU Erlangen-
Nürnberg, Siemens Medical Solutions, Erlangen, Germany
17: Prognostic value of a negative adenosine stress perfusion CMR in
patients with suspected coronary artery disease.
G. von der Recke, D. Hardung, K. Miszalski-Jamka, B. Saxler, Jan
Schnapauff, H. Omran. St.-Marien-Hospital, Bonn, Germany
12:51 - 14:15
Lunch (Klimt Room)

12:51 - 14:15
Nucleus Meeting (Berg Room)

14:15 - 15:50
SESSION III
Assessment of CAD – The clinical approach
Chair:
Udo Sechtem (Stuttgart, Germany)
Frank Rademakers (Leuven, Belgium)
18: Perfusion/Viabitity is more important than luminography
19: Luminography is equivalent to Perfusion/Viability

14:45 -15:00
20: The radiation issue
21: MSCT vs. MRI
Panel discussion

15:45 - 16:45
Coffee break and Poster Presentation I (16:00 – 16:40)

16:00 - 16:40

Poster Session I / I
Chair:
Katharina Kiss (Vienna, Austria)

16:00 -16:05
P1: Coronary Artery And Viability Evaluation In Polyarteritis Nodosa,
Microscopic Polyangiitis And Wegener Granulomatosis Using MRI

S Mavrogeni, TC Karagiorga, MN Manoussakis, M Douskou, HM Moutsopoulos, DV Cokkinos. Onassis Cardiac Surgery Center, Dept Pathophysiology University of Athens, P2: Reduction in interstudy variability of cardiac magnetic resonance
imaging by identification of mitral valve plane and apex on long axis
images.

S W M. Kirschbaum, RJM. van Geuns, T. Baks, JP. Aben, F. Cademartiri, PJ. de Feyter. Erasmus medical center, Rotterdam
P3: Cardiac MRI in Constrictive Pericarditis: Diagnostic
Characteristics and Identification of Aetiology

Ronan J Curtin MD, Srikanth Sola MD, Michael K Banbury MD, Eugene H Blackstone MD, Allan L Klein MD. Cleveland Clinic Foundation, USA P4: Comparison of SSFP and IR GRE techniques for measurement of
total myocardial mass – influence of applied contrast dosage and
implication for relative infarct size assessment.

Grothues Fa, Boenigk Ha, Ghanem Aa, Schwerdtfeger Aa, Bartels Da, Alpers Sa, Tempelmann Cb, Klein Hua. Department of Cardiology, Otto-von-Guericke-University, and Department of Neurology II, Otto-von-Guericke-University, P5: Heart rate variability influences the image quality of coronary
MRA in patients with normal sinus rhythm.

Tarinee Tangcharoen, M.D., Cosima Jahnke, M.D., Uwe Koehler, Ph.D., Bernhard Schnackenburg, Ph.D., Christoph Klein, M.D., Eckart Fleck, M.D., Eike Nagel, M.D. Department of Internal Medicine/Cardiology, German Heart Institute, Berlin, Germany P6: Systematic analysis of cardiac morphology and function in
patients with Brugada syndrome: magnetic resonance imaging
findings.

O. Catalano, S. Antonaci, M. Mussida, G. Moro, F. Cobelli, E. Ronchetti,
R. Bloise, C. Napolitano, S. Priori. IRCCS Fondazione Salvatore Maugeri,
Pavia, Italy
P7: First Application of Myocardial T1 Mapping for the Assessment
of Cardiac Amyloidosis.

Daniel R Messroghli, Ralf Wassmuth, Mirko Froehlich, Andreas Greiser, Rainer Dietz, and Jeanette Schulz-Menger P8: Diagnosis and Quantification of Atrial and Ventricular Septal
Defects by Contrast-Enhanced Magnetic Resonance Imaging.
Bernhardt P, Levenson B, Renner P, Strohm O. Cardiac MRI at the Hospital Agatharied, Hausham, Germany; Cardiac praxis, Berlin, Germany; MRI-Center at the St.-Gertrauden-Hospital, Berlin, Germany
16:00 - 16-40
Poster Session I / II
Chair:
Igor Klem (Stuttgart, Germany)

16:00 -16:05
P9: Embolic risk factors in atrial fibrillation determined by cardiac
magnetic resonance in comparison to transesophageal
echocardiography.

Bernhardt P, Pilz G, Klos M, Bräuner G, Höfling B. Cardiac MRI at the P10: Atrio-ventricular function and interaction in patients after
Fontan operation: a magnetic resonance study.
Klimes K , Ovrutski S., Abdul-Khaliq H., Hui W., Spors , Alexi- Meskishvili , Felix R. Department of congenital heart defects and Paediatric Cardiology, Deutsches Herzzentrum Berlin, Department of Radiology and Nuclear Medicine, Charité Campus Virchow-Klinikum , Department of Thoracic and Cardiovascular Surgery, Deutsches Herzzentrum Berlin
16:10 -16:15
P11: Presentation, Patterns of Myocardial Damage and Clinical
Course of Viral Myocarditis.

Heiko Mahrholdt, Anja Wagner, Claudia C. Deluigi, Eva M. Kispert, Stefan Hager, Gabriel Meinhardt, Holger Vogelsberg, Reinhard Kandolf and Udo Sechtem. Division of Cardiology, Robert-Bosch-Medical Center, Stuttgart, Germany
16:15 -16:20
P12: A New Technique for Assessing Myocardial Ischemia using
the BOLD Effect.
Jordin D. Green, Ph.D., Andreas Kumar, MD, Matthias G. Friedrich, MD. Siemens Medical Solutions, Calgary, AB, Canada; University of Calgary, Calgary, AB, Canada P13: CMR-derived LVOT-quantification allows reliable
differentiation without need for provocation in HCM.
Jeanette Schulz-Menger, Ralf Wassmuth, Hassan Abdel-Aty, Daniel Messroghli, Matthias G Friedrich, Rainer Dietz Franz-Volhard-Klinik, Charité Campus Buch, Universitätsmedizin Berlin, Helios-Kliniken, Berlin, Germany; Stephenson CMR Centre, Department of Cardiac Sciences, University of Calgary, P14: Contrast enhanced CMR does not show a specific pattern of
delayed contrast enhancement in patients with severe aortic
stenosis.

Gabriel Meinhardt, Marcus Honold, Holger Vogelsberg, Claudia C. Deluigi, Christine Goedecke, Heiko Mahrholdt and Udo Sechtem. Robert Bosch Med. Ctr., Stuttgart, Germany P15: Biplanar Measurements of Left Atrial Area and Volume
Show High Reproducibility and Good Correlation to 3D
Volumetry.
Mirko Fröhlich, Christoph Tillmanns, Lorenzo Monti, Daniel Messroghli, Ralf Waßmuth, Rainer Dietz, Jeanette Schulz-Menger Franz-Volhard-Klinik, Charité Campus Buch, Universitätsmedizin Berlin, Helios-Kliniken, Berlin, Germany P16: Intra-Abdominal Fat is a Strong Predictor of Vascular
Hyperemic Responsiveness of the Superficial Femoral Artery.

Juerg Schwitter, MD, Markus Oelhafen, PhD, Barbara M. Wyss, MD,
Beatrice Amann-Vesti, MD, Thomas F. Lüscher, MD, Peter Boesiger, PhD
University Hospital Zurich, Clinic of Cardiology and Cardio Vascular
Center, University of Zurich and Swiss Federal Institute of Technology,
Institute of Biomedical Engineering and Division of Angiology, University
Hospital Zurich, Switzerland

16:00 - 16:40

Poster Session I / III
Chair:
Filipo Civaia (Monaco)

16:00 -16:05
P17: Comparison of MR coronary angiography before and after
adenosine stress first pass perfusion.
Christoph Klein, Tarinee Tangcharoen, Bernhard Schnackenburg, Cosima Jahnke, Eckart Fleck, Eike Nagel. German Heart Institute Berlin, Berlin, Germany, Philips Medical Systems, P18: Assessment of myocardial viability by the QRS Selvester Score.
Comparison with Contrast-Enhanced Magnetic Resonance.

B. Belge, C. Brohet, A. Pasquet, J-L Vanoverschelde, Gerber. Cliniques Universitaires Saint-Luc, Brussels, Belgium P19: Planimetric and continuity equation assessment of aortic valve
area by cardiac magnetic resonance. Comparison with transthoracic
and transesophageal echocardiography.

AC. Pouleur, JB. Le Polain De Waroux, A. Pasquet, D. Vancraeynest, JL. Vanoverschelde, B. Gerber. Cliniques Universitaires Saint-Luc, Brussels, Belgium. P20: Reproducibility and accuracy of left ventricular mass
measurement with real-time three-dimensional echocardiography:
comparison with magnetic resonance imaging.

AC. Pouleur, JB. Le Polain De Waroux, A. Pasquet, B. Gerber, D. Vancraeynest, P. Allain, O. Gerard, JL. Vanoverschelde Cliniques Universitaires Saint-Luc, Brussels, Belgium, Philips Medical System Research, Paris, France P21: Equal accuracy of semi-automated 3D echocardiography
estimates of left ventricular mass in patients with and without wall
motion abnormalities: comparison with cardiac magnetic resonance.

J-B. Le Polain De Waroux, AC. Pouleur, D. Vancraeynest, A. Pasquet, B. Gerber, O. Gerard, P. Allain, JL. Vanoverschelde Cliniques Universitaires Saint-Luc, Brussels, Belgium, Philips Medical System Research, Paris, France P22: Myocardial edema is a feature of Tako-Tsubo cardiomyopathy
and is related to the severity of global and regional systolic
dysfunction.

Hassan Abdel-Aty, Myra Cocker, Abdullah Alsehly and Matthias G. Friedrich. Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada P23: Myocardial edema is a feature of hypertrophic cardiomyopathy
and is related to the severity of hypertrophy.

Hassan Abdel-Aty, Myra Cocker, Abdullah Alsehly and Matthias G. Friedrich. Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada P24: Relation of tissue injury to left ventricular function in patients
with acute myocarditis – A Cardiovascular MR study.

Myra Cocker, Hassan Abdel-Aty, and Matthias G. Friedrich. Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada
16:45 - 18:20
SESSION IV
CMP/Heart
Failure/Myocarditis
Chair:
Bernhard Gerber (Brussels, Belgium)
Dudley Penell (London, UK)
22: CMP
23: Heart Failure
24: Myocarditis
25: Case presentation 1
Jeanette Schulz-Menger (Berlin, Germany) 26: Case presentation 2
27: Case presentation 3

18:00 - 18:21
Oral abstract presentation

18:00 -18:07
28: Prediction of ventricular arrhythmias in patients with ischemic heart
failure using delayed enhancement MRI
.
S. Sola, R. Setser, D. Sauri, M. Lieber , M. Desai, R. White
Cleveland Clinic Foundation, USA
29: Late-enhancement in MRI associates with inflammatory changes
in myocardial biopsies and serum in HCM.
P. Sipola, M. Laakso, K. Peuhkurinen, V. Kärjä, K. Punnonen, J. Kuusisto.
Kuopio University Hospital, Dept of Radiology, Medicine Pathology , and
Clinical Chemistry, Finland
30: Systematic analysis of cardiac morphology and function in patients
with Brugada syndrome: magnetic resonance imaging findings.

O. Catalano, S. Antonaci, M. Mussida, G. Moro, F. Cobelli, E. Ronchetti ,
R. Bloise, C. Napolitano, S. Priori. IRCCS Fondazione Salvatore Maugeri,
Pavia, Italy
18:21 - 19:00
SESSION V
Results of Multicenter trials
Chair:
Albert van Rossum (Amsterdam, The Netherlands)
Frank Rademakers (Leuven, The Netherlands)

18:20 -18:30
31: MR-Impact
32: MI Study
33: Mesa-trial
34: Iceland Study

Buses leaving at 19:15

Social Event at 19:30 – sponsored by GE Healthcare
Kunsthistorisches Museum Wien (Kuppelsaal)
Saturday May 20, 2006

08:30 - 10:05
SESSION VI
Vascular, Congenital, Masses
Chair:
Guillem Pons-Llado (Barcelona, Spain)
Heiko Marholdt (Stuttgart, Germany)
35: Vascular
36: Congenital diseases
37: Cardiac masses
38: Case Presentation 1
39: Case Presentation 2
Albert van Rossum (Amsterdam, The Netherlands) 40: Case Presentation 3

09:45 - 10:06
Oral Abstract Presentation

09:45 - 09:52
41: 3T CMR in patients after acute and chronic myocardial infarction: an
initial experience.

R Nijveldt, A. Hirsch, AM Beek, MBM Hofman, AM Spijkerboer, JJ Piek, AC van Rossum. VU University Medical Center, Amsterdam; Amsterdam Medical Center, Amsterdam; Netherlands 42: Microvascular obstruction detected by cardiovascular magnetic
resonance in patients with first anterior AMI treated with primary PCI.
Preliminary report.

D. Piotrowska, L. Kownacki, A. Cieszanowski, G. Opolski, L. Krolicki. Department of Nuclear Medicine, Department of Cardiology, I and II Department of Radiology Medical University of Warsaw, Poland 43: Structural Changes of the Inferoseptal Left Ventricular
Myocardium are associated with Mutations Causing Hypertrophic
Cardiomyo-pathy: the Role of Cardiac Magnetic Resonance Imaging
in Early Identification of HCM mutation carriers.

T. Germans, AAM. Wilde, PA. Dijkmans, W. Chai, O. Kamp, YM. Pinto,
AC.Van Rossum. VU University Medical Center, Amsterdam, Netherlands;
Academic Medical Center, Amsterdam, Netherlands; ICIN, Utrecht,
Netherlands; University Hospital Maastricht, Maastricht, Netherlands
10:06 - 11:00
Coffee Break and Poster Presentation II (10:15 – 10:55)

10:15 - 10:55
Poster Session II / I
Chair:
Heiko Marholdt (Stuttgart, Germany)

10:15 -10:20
P25: Wall motion abnormalities and fat infiltration assessed by MRI
in patient with frequent premature ventricular complexes with LBBB
morphology and inferior axis.

G.D. Aquaro, E.Strata, G. Di Bella, A. M. Sironi, D. De Marchi, M. Deiana, P. Keilberg, A. Pingitore, M.Institute of Clinical Physiology, CNR, Pisa, Italy P26: Delayed enhancement evaluation of necrotic and perinecrotic
tissue in patient with frequent premature ventricular complexes.

G.D.Aquaro, G.Di Bella, A.Pingitore, E.Strata, D.DeMarchi,D.Rovai, M.lombardi. Institute of Clinical Physiology, CNR, Pisa, Italy P27: LV dysfunction in noncompaction cardiomyopathy patients:
a global or regional problem?
K. Caliskan MD, RJ van Geuns MD PhD, AHHM Balk MD PhD. Departments of Cardiology and Radiology, P28: Relation between infarct size and left ventricular function in
acute and chronic myocardial infarction.

D. Piotrowska, L. Kownacki, A. Cieszanowski, G. Opolski, L. Krolicki. Depatrment of Nuclear Medicine, Department of Cardiology, I and II Department of Radiology Medical University of Warsaw, Poland P29: MR imaging of right ventricular dysfunction in patients with no
clinical symptoms of ARVD.

D. Piotrowska, L. Kownacki, A. Cieszanowski, G. Opolski, L. Krolicki. Department of Nuclear Medicine, Department of Cardiology, I and II Department of Radiology Medical University of Warsaw, Poland P30: Cardiac Complications Of Renal Disease (CCORD): CMR
findings.

Neil Filipchuk, Hassan Abdel-Aty, and Matthias G. Friedrich Stephenson
CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments
of Cardiac Sciences and Radiology, University of Calgary, Canada
P31: A Proposed standard for Cardiovascular Magnetic Resonance
reporting.
DR Kaura, N Filipchuk, D Patton, A Al Sehly, H Abdel-Aty, A Kumar, MG Friedrich. Stevenson CMR Centre, University of Calgary, Canada P32: Rapid analysis of left ventricular function in patients following
acute myocardial infarction using cine CMR.

R Nijveldt, AM Beek, RJ van der Geest, MBM Hofman, AC van Rossum.
VU University Medical Center, Amsterdam; Leiden University Medical
Center, Leiden; The Netherlands

10:15 - 10:55
Poster Session II / II
Chair:
Jeanette Schulz-Menger (Berlin, Germany)

10:15 -10:20
P33: Right ventricular fractional shortening is a more reliable
measure for right ventricular function than TAPSE.

R Nijveldt, T Germans, GP McCann, AM Beek, AC van Rossum. VU University Medical Center, Amsterdam, the Netherlands; University Hospitals Leicester, United Kingdom P34: Measurement of age related effects on left atrial volume and
function: assessment with cardiac magnetic resonance imaging

Tjeerd Germans, Marco J.W. Götte, Robin Nijveldt, Aernout M. Beek, Jean G.F. Bronzwaer, Walter A. Paulus, Albert C. van Rossum . VU University Medical Center, Amsterdam, the Netherlands P35: Assessment of regional myocardial strain using strain-
encoded MRI (SENC) in patients with unimpaired left ventricular
function.

Thomas Thouet, Sebastian Kelle, Ahmed Fahmy, Ingo Paetsch, Nael Osman, Eike Nagel. Internal medicine/Cardiology; German Heart Institute Berlin; Dept. Radiology, Johns Hopkins Baltimore, USA P36: Impact of exercise capacity on myocardial high-energy
phosphate metabolism: A 31-Phosphorous magnetic resonance
spectroscopy study.

Klug G, Zwick RH, Wolf C, Schocke MF, Frick M, Jaschke W, Pachinger O, Metzler B. Clinical Division of Cardiology, Innsbruck Medical University Radiology Department, Innsbruck Medical University, Austria P37: Delayed enhancement in DCM is unrelated to virus persistence
or the presence of inflammation in myocardial biopsies.

Jörg Ruppert, Sönke Langner, Alexander Staudt, Andreas Streitbörger, Norbert Hosten, Stefan Felix Departments of Cardiology and Radiology, Ernst-Moritz-Arndt-University, Greifswald, Germany P38: Perfusion of the left ventricular myocardium as revealed by 3T
MRI.

Anders Hervold, Stig F. Samnøy, Birgit Schulz and Terje H. Larsen. Haukeland University Hospital; Departments of Cardiology, Clinical engineering and Radiology, Norway P39: 3D Vector Visualization of Ventricular Wall Motion across a
volume by the use of 3T MRI.

Stig F. Samnøy, Anders Hervold, Gottfried Greve, Terje H. Larsen. Haukeland University Hospital, Depts. of Clinical Engineering, Cardiology, Radiology. Bergen University College, Norway P40: Cardiac function analysis with MRI: Assessment of
measurement accuracy in a prospective multicenter study.

Claudia Fröhlich, Katrin Klimes, Peter Barth , Andrea Kelter-Klöpping , Julia Krüger, Felix Berger, Roland Felix, Hans Meyer, Philipp Beerbaum,Titus Kuehne, Matthias Gutberlet, Humboldt University Berlin, Charité, Department of Radiology, Deutsches Herzzentrum Berlin, Department of Congenital Heart Diseases and Pediatric Cardiology, Deutsches Herz und Diabeteszentrum Bad Oeynhausen, Department of Pediatric Cardiology, Germany 10:15 - 10:55
Poster Session II / III
Chair:
Sanjay Prasad (London, UK)
P41: Cardiac MRI for the Assessment of Risk of Sudden Cardiac
Death in Patients with Hypertrophic Cardiomyopathy.

L. Toth, R. Faludi, E. Fodi, M. Knausz, A. Varga-Szemes, I. Repa, L.
Papp, T. Simor. University of Pecs Heart Institute, Pecs, Hungary
P42: Safety and complications of Adenosine-Stress-CMR in the
evaluation of coronary artery disease.
D. Hardung, H. Omran, K. Miszalski-Jamka, J. Schnapauff, B. Saxler, G.
von der Recke. St.-Marien-Hospital Bonn-Venusberg, Bonn, Germany
P43: The dark rim artifact in first pass myocardial perfusion:
Influence of spatial and temporal resolution.
Nidal Al-Saadi, Geir Torheim, H. Glenn Reynolds, Daniele De Marchi, Silvia Burchielli, Massimo Lombardi. Institute of Cardiac MRT, Berlin, Germany; GE Healthcare AS, Oslo, Norway; GE Healthcare, Boston, USA; MRI Laboratory, C.N.R., Pisa, Italy P44: Is standard echocardiography really sufficient for diagnosing
previously unknown chronic myocardial infarction? A comparison to
cardiac magnetic resonance.

Giso von der Recke, MD, Heyder Omran, MD, Karol Miszalski- Jamka, MD, Christoph Hammerstingel, MD, Bernd Saxler, Jan Schnapauff, David Hardung, MD. St.-Marien-Hospital, Bonn, Germany P45: Regional myocardial perfusion mapping of CMR images in
comparison to SPECT.
J. Misko, A. Teresinska, E. Skrobowska, C. Kepka, L. Chojnowska, K. Kukula, M. Dabrowski, M. Skwarek, A. Warczynska, W. Ruzyllo. Miedzyleski Specialistic Hospital, Institute of Cardiology, Medical Military Institute,Warsaw, Poland P46: Imaging Cardiac Amyloid with CMR
Bryant T, Peebles CR, Harden SP. Department of Cardiothoracic Radiology, Southampton General Hospital, Southampton, UK P47: Manual Contouring vs. contour detection for left ventricular
time volume curve analysis to demonstrate diastolic dysfunction in
patients with fabrys disease
.
Juli CF, Peebles C, Widmer U, Froehlich J, Eckhardt BP. Cantonal Hospital Winterthur, Inst. for Clin. Radiology, MRI-Centre, Switzerland, Dept. of Medicine, Zurich University Hospital, Switzerland, Southampton University Hospital, Dept. Cardiothoracic Radiology, United Kingdom P48: The Influence of the Introduction of the “Late Enhancement”
Technique on the Indication for Cardiac Magnetic Resonance
Imaging: Single-Centre Experience.

Hafner T, Marko C, Gstaltner A, Strau G, Sellner Y, Böck R, Podczeck-
Schweighofer A. 5th Department for Internal Medicine with Cardiology,
Kaiser-Franz-Josef-Spital, Vienna, Austria

11:00 - 12:36

SESSION VII
CONTRAST AGENTS in CVMR
Chair:
Matthias Friedrich (Calgary, Canada)
Igor Klem (Stuttgart, Germany)

11:00 -11:15
44: Blood pool contrast agents in CVMR
45: Use of CA in viability imaging
46: Mapping of Myocardial Metabolism in Ischemic Hearts using
Hyperpolarized 13C-puruvate Magnetic Resonance Imaging
47: Case presentation 1
48: Case presentation 2

12:15 - 12:36
Oral abstract presentation

12:15 -12:22
49: Evidence of more severe left ventricular remodeling in
hemodialysis as compared with peritoneal dialysis. Insights from
CMR.

Neil Filipchuk, Hassan Abdel-Aty, and Matthias G. Friedrich Stephenson
CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments
of Cardiac Sciences and Radiology, University of Calgary, Canada
50: Detection of chronic myocardial infarction in patients undergoing
MR coronary artery imaging using the intravascular CA MS-325.

Thouet T, Kelle S, Schnackenburg B, Kokocinski T, Fleck E, Nagel E. Internal Medicin/Cardiology; German Heart Institute Berlin, Germany 51: Differences of Rosuvastatin and Simvastatin on Myocardial High-
Energy Phosphate Metabolism: A 31-Phosphorous Magnetic
Resonance Spectroscopy Study.

Klug G, Frick M, Wolf C, Zwick RH, Schocke MF, Lechleitner M, Jaschke W, Pachinger O, Metzler B. Clinical Division of Cardiology, Innsbruck Medical University; Radiology Department, Innsbruck Medical University; Clinical Division of General Internal Medicine, Innsbruck Medical University, Austria
12:36 - 14:00
Lunch (Klimt Room)

14:00 - 15:15
SESSION VIII
INDUSTRY FORUM
Chair:
Peter Buser (Basel, Switzerland)
Herbert Frank (Tulln, Austria)

14:00 -14:15
52: Bracco
53: Siemens
54: Schering
Hanns-Joachim Weinmann (Berlin, Germany) 55: GE Healthcare
Patrice Hervo, MR Advanced Application Europe (Buc, France) 56: Philips

15:15 - 16:00
Coffee break

16:00 - 17:15
SESSION IX
Chair:
Jeanette Schulz Menger (Berlin, Germany)
Philip Kilner (London, UK)

16:00 -16:15
57: Interventional MRI
58: Hyperpolerized Contrast Media – Malmö 9
59: Plaque imaging
60: Do we need 3 T imaging
Sebastian Globits (St. Pölten, Austria) 61: The future of CVMR in Europe

17:15 - 19:00
SESSION X
The CMR Exam will be a written exam consisting of two parts. One part is a multiple choice test, one part case studies.

Source: http://eurocmr2006.medconvent.at/pdf/EuroCMR_final_programme.pdf

(microsoft word - resumen-comentario cuesti\363n 94.doc)

RESUMEN-COMENTARIO DE LA CUESTIÓN 94 A Tomás de Aquino se le conoce como al autor de una síntesis entre aristotelismo y cristianismo. Bien, una síntesis no es lo mismo que una coincidencia plena: ambas éticas tienen carácter teleólogico (toda la argumentación se construye sobre el fin del ser humano), ambas son éticas materiales, ambas sitúan a la felicidad como el fin suprem

hermandiagnostics.be

The AccuSign ® MET test uses solid-phase immunoassay technol- ogy for the qualitative detection of methamphetamine in humanurine. The test is based on the principle of the highly specificimmunochemical reactions between antigens and antibodies whichare used for the analysis of specific substances in biological fluids. The test relies on the competition between the drug conjugates andthe drug

Copyright © 2014 Medical Pdf Articles